1 terminated. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
Follow Relapsed T-Cell Lymphoma: new trials by email Literature Review of Relapsed T-Cell Lymphoma trials Research Report on Relapsed T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma PEG-L-asparaginase, Dexamethasone acetate - T-Cell Lymphoma, Relapsed T-Cell Lymphoma | Early Phase 1 | Terminated | Dana-Farber Cancer Institute | 2 | 2013-07-01 | 2017-03-06 |
Lymphoma, T-Cell (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
dexamethasone acetate (1) · pegaspargase (1)
Dana-Farber Cancer Institute (1)
United States (1)